ロード中...
Targeting mTOR in Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes approximately 25% of cancer diagnoses among children and teenagers. Pediatric patients have a favourable prognosis, with 5-years overall survival rates near 90%, while adult ALL still correlates with poorer surv...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406494/ https://ncbi.nlm.nih.gov/pubmed/30795552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8020190 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|